BRITTNEY ARMSTRONG: Open Payments
NPI 1801546098 · ANGLETON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 76 payments from 12 companies in 2025. Trend: 2023 $60 · 2024 $581 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 32 | $420 |
| Gilead Sciences, Inc. | 7 | $251 |
| Madrigal Pharmaceuticals | 15 | $173 |
| ABBVIE INC. | 9 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| Genentech USA, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Astellas Pharma US Inc | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
Products named: XIFAXAN, REZDIFFRA, Livdelzi, TEFLARO, LIVTENCITY, TERLIVAZ, Tecentriq, AVYCAZ.
Industry payments across TX — which companies pay providers there.
